- 全部删除
- 您的购物车当前为空
EZH2-IN-15(SHR2554) 是zeste 2组蛋白修饰增强子(EZH2)的特异性抑制剂。EZH2在许多人类癌症中异常过表达,通过调节Treg 活性来控制适应性反应。肿瘤内EZH2的表达也被证明可以控制先天免疫。
为众多的药物研发团队赋能,
让新药发现更简单!
EZH2-IN-15(SHR2554) 是zeste 2组蛋白修饰增强子(EZH2)的特异性抑制剂。EZH2在许多人类癌症中异常过表达,通过调节Treg 活性来控制适应性反应。肿瘤内EZH2的表达也被证明可以控制先天免疫。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 997 | In stock | |
5 mg | ¥ 2,390 | In stock | |
10 mg | ¥ 3,660 | In stock | |
25 mg | ¥ 5,850 | In stock | |
50 mg | ¥ 7,890 | In stock | |
100 mg | ¥ 10,600 | In stock |
EZH2-IN-15 相关产品
产品描述 | EZH2-IN-15 (SHR2554) is a specific inhibitor of the zeste 2 histone modification enhancer (EZH2).EZH2 is aberrantly overexpressed in many human cancers and controls adaptive responses by regulating Treg activity. EZH2 expression in tumors has also been shown to control innate immunity. |
体外活性 | 用CTG方法测的,EZH2-IN-15对EZH2野生型的IC50=0.87 nM,对Pfeiffer 细胞中H3K27me3的IC50=1.63 nM。[3] |
别名 | SHR2554 |
分子量 | 548.72 |
分子式 | C32H44N4O4 |
CAS No. | 2098545-98-1 |
Smiles | CCN(C1CCOCC1)c1cc2oc(CN3CCCCC3)cc2c(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1CC |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (91.12 mM), Sonication is recommended. ![]() | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容